Clinical Trial Update: Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov update on a Phase 1/Phase 2 study for Charcot-Marie-Tooth disease, type 2S (CMT2S) in an individual patient; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING